Evidence map›Paper›PMID 17040933›Full record

SynthesisThorax2007

Outcome of occupational asthma after cessation of exposure: a systematic review.

George Rachiotis, Rashna Savani, Andrew Brant, Stephanie J MacNeill, Anthony Newman Taylor, Paul Cullinan

Abstract readSystematic Review
In one paragraph

Synthesis in Thorax, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Contribution of host factors and workplace exposure to the outcome of occupational asthma.European respiratory review : an official journal of the European Respiratory Society · 2012
    Pooled it
  2. What is the optimal management option for occupational asthma?European respiratory review : an official journal of the European Respiratory Society · 2012
    Pooled it
  3. Work-Related Asthma: An Occupational Medicine Perspective.Allergy, asthma & immunology research · 2026
    Review
  4. Review
  5. Occupational Respiratory Allergy to Flour in the Modern Era.Current allergy and asthma reports · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Causes and Phenotypes of Work-Related Asthma.International journal of environmental research and public health · 2020
    Review
  10. Progress in Occupational Asthma.International journal of environmental research and public health · 2020
    Review
  11. Workplace interventions for treatment of occupational asthma.The Cochrane database of systematic reviews · 2019
    Review
  12. Review
  13. Medical surveillance and long-term prognosis of occupational allergy due to platinum salts.International archives of occupational and environmental health · 2017
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Performing a lung disability evaluation: how, when, and why?Journal of occupational and environmental medicine · 2014
    Review
  19. Article
  20. Work-related asthma and employment status--38 states and District of Columbia, 2006-2009.The Journal of asthma : official journal of the Association for the Care of Asthma · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

George RachiotisDepartment of Occupational and Environmental Medicine, Imperial College (NHLI), 1b Manresa Road, London SW3 6LR, UK.
Rashna Savani
Andrew Brant
Stephanie J MacNeill
Anthony Newman Taylor
Paul Cullinan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with occupational asthma, and their medical advisers, need valid information about the prognosis of their disease.

methodsA systematic review of the published literature on the symptomatic and functional outcomes of occupational asthma was carried out after avoidance of exposure to the causative agent. Through a full search of electronic and bibliographic sources, original studies documenting complete recovery from asthma (n = 39,1681 patients) or improvement in non-specific bronchial hyper-responsiveness (NSBHR; n = 28,695 patients) were identified. The median duration of follow-up was 31 (range 6-240) months for studies of symptomatic recovery and 37 (6-240) months for studies of NSBHR. Most studies were of patients recruited from special clinics.

resultsReported rates of symptomatic recovery varied from 0% to 100%, with a pooled estimate of 32% (95% CI 26% to 38%). These rates were lower with increasing age (p = 0.019) and among clinic based populations (p = 0.053). Patients with the shortest durations of exposure (< or =76 months) had the highest rate of recovery (36%; 95% CI 25% to 50%), but the effect was not linear. The pooled prevalence of persistent NSBHR at follow-up was 73% (95% CI 66% to 79%). This figure was higher among patients whose disease was due to high-molecular-weight agents (p = 0.006) and, less clearly, those from clinic-based populations (p = 0.561). In between-study comparisons, no clear patterns of improvement relating to total duration of exposure or follow-up were found. From within-study comparisons there was some evidence that a shorter duration of symptoms was associated with a higher rate of symptomatic recovery.

conclusionThe available data on the prognosis of occupational asthma are insufficiently consistent to allow confident advice to be given to patients with the disease. Clinicians and epidemiologists with an interest in this disease should consider a collaborative and carefully standardised study of the prognosis of occupational asthma.

Indexed as

AdultAsthmaHumansMiddle AgedOccupational DiseasesOccupational ExposurePrognosisTime Factors

Identifiers

PMID17040933
PMCPMC2111252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.